Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 527123 in psoriasis
2006-006601-83Phase 2Completed
- Sponsor
- Schering-Plough Research Institute
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in psoriasis and plaque psoriasis comparing SCH 527123 with Placebo (2 arms). Primary endpoint: Percent change from baseline to Day 29 in PASI score. Started Mar 2007; status: completed.
02
Drugs
navarixin
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2006-006601-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006601-83.